Found 22 matching trials
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor PHASE1 This is a phase Ib single arm, open-label, multiple dose, dose escalating, ...
Show More Location
Oncology Institute of Southern Switzerland (IOSI)
Learn More & Join Trial
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer PHASE2 This research study is studying a combination of targeted therapies as a po...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer PHASE1 This is a dose-escalation Phase Ib clinical trial in 18 patients with newly...
Show More Location
California Research Institute
Learn More & Join Trial
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer PHASE1 This is a Phase 1/2, open-label, randomized, dose finding and dose expansio...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Investigation Of The Metabolism, And Excretion Of [14c]-PF-05212384 In Healthy Male Volunteers PHASE1 The purpose of the study is to characterize how PF-05212384 is metabolized ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) PHASE3 This is a Phase 3, open-label, randomized, clinical trial evaluating the ef...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer PHASE1 Phase 1 study to evaluate the safety and effect of Gedatolisib and PTK7-ADC...
Show More Location
IU Simon Cancer Center
Learn More & Join Trial
Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer PHASE2 Phase II Pilot Study of Trastuzumab Biosimilar (Herzuma®) plus Gedatolisib ...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers PHASE1 This study is designed to determine the RP2D of gedatolisib in combination ...
Show More Status
Active Not Recruiting
Location
Northwestern University Feinberg School of Medicine
Learn More & Join Trial
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) PHASE3 This is a Phase 3, open-label, randomized, clinical trial evaluating the ef...
Show More Location
City of Hope Medical Center
Learn More & Join Trial